Bispecific antibodies with broad neutralization potency against SARS-CoV-2 variants of concern.
Adonis A RubioViren A BaharaniBernadeta DadonaiteMegan ParadaMorgan E AbernathyZijun WangYu E LeeMichael R EsoJennie PhungIsrael RamosTeresia ChenGina El NesrJesse D BloomPaul D BieniaszMichel C NussenzweigChristopher O BarnesPublished in: bioRxiv : the preprint server for biology (2024)
Bispecific antibodies with a highly cross-reactive NTD antibody demonstrate resilience to SARS-CoV-2 variants of concern.